Merck & Co., Inc. Website

Merck & Co., Inc.

NYSE-MRK

Income Statement
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM

Total Revenues

39,121

41,518

48,704

59,283

60,115

62,480

Total Revenues % Chg.

-7.5%

6.1%

17.3%

21.7%

1.4%

7.1%

Cost of Goods Sold, Total

11,060

11,990

13,466

17,206

15,915

15,128

Gross Profit

28,061

29,528

35,238

42,077

44,200

47,352

Selling General & Admin Expenses, Total

8,829

8,569

9,403

9,669

9,884

9,847

R&D Expenses

8,594

10,564

11,942

11,918

18,342

17,739

Other Operating Expenses, Total

17,423

19,133

21,345

21,587

28,226

27,586

Operating Income

10,638

10,395

13,893

20,490

15,974

19,766

Interest Expense, Total

-893

-831

-806

-962

-1,146

-1,240

Interest And Investment Income

274

118

36

157

365

285

Net Interest Expenses

-619

-713

-770

-805

-781

-955

Income (Loss) On Equity Invest.

—

—

—

—

—

—

—

—

Currency Exchange Gains (Loss)

-187

-145

-297

-237

-370

-392

Other Non Operating Income (Expenses)

124

71

256

681

420

271.5

EBT, Excl. Unusual Items

9,956

9,608

13,082

20,129

15,243

18,690.5

Restructuring Charges

-915

-705

-868

-666

-933

-1,022

Merger & Related Restructuring Charges

—

-1,745

-4,288

—

—

-11,409

-1,906

Impairment of Goodwill

—

—

—

-162

—

—

—

—

—

Gain (Loss) On Sale Of Investments

170

1,338

1,940

-1,419

340

266

Gain (Loss) On Sale Of Assets

—

—

—

—

—

—

—

—

—

Asset Writedown

-172

-90

-275

-1,600

-779

-779

In Process R&D Expenses

—

—

—

—

—

—

—

—

—

—

Legal Settlements

—

—

—

—

—

—

-573

-0.5

Other Unusual Items

39

—

—

—

—

—

EBT, Incl. Unusual Items

7,171

5,863

13,879

16,444

1,889

15,249

Income Tax Expense

1,565

1,340

1,521

1,918

1,512

1,497

Earnings From Continuing Operations

5,606

4,523

12,358

14,526

377

13,752

Earnings Of Discontinued Operations

—

—

—

—

—

4,153

2,548

704

—

—

—

Minority Interest

84

-4

-13

-7

-12

-16

Net Income

9,843

7,067

13,049

14,519

365

13,736

Net Income to Common Incl Extra Items

9,843

7,067

13,049

14,519

365

13,736

Net Income to Common Excl. Extra Items

5,690

4,519

12,345

14,519

365

13,736

Total Shares Outstanding

2,539

2,530.2

2,527.6

2,537.8

2,531.6

2,535.6

Weighted Avg. Shares Outstanding

2,565

2,530

2,530

2,532

2,537

2,534.5

Weighted Avg. Shares Outstanding Dil

2,580

2,541

2,538

2,542

2,547

2,549.5

EPS

3.8

2.8

5.2

5.7

0.1

5.4

EPS Diluted

3.8

2.8

5.1

5.7

0.1

5.4

EBITDA

13,715

13,613

17,016

24,279

19,706

23,632

Effective Tax Rate

21.8%

22.9%

11%

11.7%

80%

9.8%